Thus, we checked for the presence of ctDNA assay variants in serial tumor tissues from 94 patients with RCB-II or RCB-III (45 HR-positive/HER2-negative, 38 TN, and 11 HER2-positive). Here, ERBB2 is linked to neoplasm.